Acta Pharmaceutica Sinica B (Nov 2023)
Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
Abstract
No abstracts available.
Acta Pharmaceutica Sinica B (Nov 2023)